Everett Harris & Co. CA Cuts Stake in Utah Medical Products, Inc. (NASDAQ:UTMD)

Everett Harris & Co. CA cut its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMDFree Report) by 34.6% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,232 shares of the medical instruments supplier’s stock after selling 2,770 shares during the quarter. Everett Harris & Co. CA owned 0.15% of Utah Medical Products worth $350,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC bought a new stake in shares of Utah Medical Products in the 2nd quarter valued at about $83,000. Victory Capital Management Inc. lifted its position in Utah Medical Products by 124.4% in the second quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier’s stock valued at $179,000 after purchasing an additional 1,482 shares during the last quarter. EntryPoint Capital LLC boosted its stake in shares of Utah Medical Products by 124.1% during the first quarter. EntryPoint Capital LLC now owns 3,240 shares of the medical instruments supplier’s stock valued at $230,000 after purchasing an additional 1,794 shares during the period. Exchange Traded Concepts LLC bought a new position in shares of Utah Medical Products in the third quarter worth approximately $304,000. Finally, Sequoia Financial Advisors LLC purchased a new position in shares of Utah Medical Products in the second quarter worth $307,000. 69.60% of the stock is currently owned by institutional investors.

Utah Medical Products Stock Up 0.9 %

Shares of UTMD opened at $66.30 on Friday. The stock has a market capitalization of $233.91 million, a P/E ratio of 14.73 and a beta of 0.08. Utah Medical Products, Inc. has a twelve month low of $64.90 and a twelve month high of $87.86. The firm has a fifty day simple moving average of $66.78 and a two-hundred day simple moving average of $67.70.

Utah Medical Products (NASDAQ:UTMDGet Free Report) last posted its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.98 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 12.41% and a net margin of 33.56%. The company had revenue of $10.40 million for the quarter.

Utah Medical Products Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 4th. Stockholders of record on Friday, September 20th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, September 20th. This represents a $1.20 annualized dividend and a dividend yield of 1.81%. Utah Medical Products’s dividend payout ratio (DPR) is presently 26.67%.

Utah Medical Products Company Profile

(Free Report)

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.

Further Reading

Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMDFree Report).

Institutional Ownership by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.